Copart: Buybacks Are Here

Copart resumed opportunistic share buybacks, deploying $500 million, signaling disciplined capital allocation and shareholder-friendly policy. The note affirms CPRT's enduring moat—duopoly dynamics, a dominant marketplace and international expansion—as underpinning long-term compounding. Recent volume softness is attributed to temporary insurance client share shifts rather than structural competitive weakness, suggesting the weakness is transitory and buybacks could be supportive for the stock.

Analysis

A capital-return program of the reported magnitude is functionally a near-term shrinkage of public float: at an estimated market cap in the low tens of billions, the mechanical share-count reduction is on the order of ~1–2%, implying immediate EPS accretion of comparable magnitude absent margin deterioration. That degree of accretion matters more for multi-strategy investors because it increases free cash yield and pushes ROIC higher without changing underlying unit economics — a lever that often compresses the required organic growth rate to maintain the same stock multiple.

Operationally, transitory account-share swings from large insurance clients create outsized quarterly P&L noise versus secular demand trends. That amplifies event risk around quarterly prints and reweights the alpha opportunity toward short-duration, event-driven trades (earnings, insurance contract renewals) rather than long-duration fundamental re-rating. Second-order beneficiaries include auction-platform technology providers and regional logistics firms that see variable utilization; a sustained rebound in salvage volumes would disproportionately flow to these suppliers and to smaller public auction peers that lack capital flexibility.

On the risk side, the biggest non-linear threats are regulatory/antitrust intervention and a prolonged downgrade in used-car pricing driven by macro or loss-frequency shocks — either can flip multiple expansion from tailwind to headwind over 12–36 months. The contrarian angle is that the market may be pricing this name as cyclically impaired rather than financially flexible: if volumes normalize within 2–4 quarters, EPS accretion plus multiple re-rating creates asymmetric upside; conversely, if client-share shifts persist or a transparency regulation passes, downside could be swift and steeper than typical operating leverage suggests.

Key Decisions for Investors

• Buy CPRT on a 3–6% intra-day pullback within the next 3 months; target a 20–30% upside over 6–12 months if volumes normalize and buyback-driven EPS accretion persists. Size at 2–4% portfolio, stop-loss -12% to control single-name event risk.
• Event-driven: establish a short-duration long ahead of the next quarterly release (hold 0–10 days around print). Use a 45–90 day call calendar or buy the stock outright with a tight pre-earnings stop (-6%) and take-profit at +15% to capture volatility-driven rebounds.
• Pair trade: long CPRT / short KAR (equal dollar notional) for 6–12 months to isolate market/used-car-cycle exposure. Rationale: CPRT’s capital flexibility should outperform a pure-auction competitor on EPS accretion; target spread capture 8–12% with max drawdown limited by weekly rebalancing and 10% stop on either leg.
• Defined-risk options: buy a 6–9 month ATM call and sell a 30–40% OTM call (call spread) sized to equal a 2% portfolio equity exposure. This provides leveraged upside to normalization while capping vega exposure; aim for 2.5–3x upside-to-loss if the thesis executes.